Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. - Wikidata - awgldk - TriplyDB

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q35183015

about

O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes Three Decades of Research on O-GlcNAcylation - A Major Nutrient Sensor That Regulates Signaling, Transcription and Cellular Metabolism Cancer metabolism and elevated O-GlcNAc in oncogenic signaling Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells O-GlcNAcylation: The Sweet Side of the Cancer.From Krebs to clinic: glutamine metabolism to cancer therapy.Bitterness in sugar: O-GlcNAcylation aggravates pre-B acute lymphocytic leukemia through glycolysis via the PI3K/Akt/c-Myc pathway.Changes in metabolic chemical reporter structure yield a selective probe of O-GlcNAc modification Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling.O-GlcNAc signaling in cancer metabolism and epigenetics Development of inhibitors as research tools for carbohydrate-processing enzymes.Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1 mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.O-GlcNAc signalling: implications for cancer cell biology.Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.Gene expression of O-GlcNAc cycling enzymes in human breast cancers Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines O-GlcNAcylation: A New Cancer Hallmark?Cracking the O-GlcNAc code in metabolism.Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells The multiple mechanisms of cell death triggered by resveratrol in lymphoma and leukemia.Cellular metabolic stress: considering how cells respond to nutrient excess.Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology.Regulation of cancer metabolism by O-GlcNAcylation.The potential role of O-GlcNAc modification in cancer epigenetics.O-GlcNAcase is essential for embryonic development and maintenance of genomic stability.Identification and characterization of a missense mutation in the O-linked β-N-acetylglucosamine (O-GlcNAc) transferase gene that segregates with X-linked intellectual disability.Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.Emerging tale of UPR and cancer: an essentiality for malignancy.O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.Aging, Metabolism, and Cancer Development: from Peto's Paradox to the Warburg Effect.Inhibition of O-GlcNAcase sensitizes apoptosis and reverses bortezomib resistance in mantle cell lymphoma through modification of truncated Bid.Profiling of Protein O-GlcNAcylation in Murine CD8+ Effector- and Memory-like T Cells.A Chemoenzymatic Histology Method for O-GlcNAc Detection.

P2860

Q26770270-8492FE50-5471-4462-BA15-E8E87F1A218C Q26853027-FAA87948-8115-4A92-B527-8442736C920B Q26859087-12476918-8869-4732-8192-304E0DFF77B6 Q27009399-627AA43D-518D-4977-A782-091B20B4E81C Q28569862-F9ABBFF0-1BB4-4E53-B0C9-4ECBB154A819 Q30540051-814093C1-DF46-4DFB-9E28-E0CAA9A6071C Q33701447-BEC11914-F8DD-45EA-B600-8246AAAB8FEF Q33834498-5E9A3042-9835-45D3-B79B-1E2D717EF9CF Q33850060-8B7CFFE7-BF4D-4AFD-8C52-AC466CC73455 Q34145247-3433C925-4C1D-423E-8084-EEE8529B9C38 Q34281873-016834BB-EF5F-447B-9D5D-92A13DE9175A Q34401725-F67677AA-489E-400C-A339-23B2BF18A5CC Q34417631-37076323-EC67-488E-B8AD-318A46302FA9 Q34488445-2C770268-324E-4462-9A2F-8FF658B7E554 Q35002612-F1EA75AD-4889-4B37-870F-C2C4283F097C Q35611316-44D30FDB-04C6-4ACD-B98C-4999DA5CB87D Q35793071-F1AB5D6E-E203-4EDD-96B8-67B1AEF469AE Q35804446-2CAD1162-E01E-48DC-A85E-A8BE2A4FE841 Q35809895-B0B52C13-B3B0-4E87-8263-2959EA52F446 Q35828619-F22DE717-4A7F-496E-8F19-BB6120067855 Q35879559-FDDFD819-4638-4C7D-8947-7AB12DA9EE1B Q36934903-05DF6ECE-231D-4A17-B7C7-2EF5BFC8F4B3 Q37086952-FE84C7A3-81BE-4B75-ACC2-AAC805CDD183 Q37197417-77E5043C-6121-4B41-9B2A-2DF5065CB4C9 Q37321175-223A4F6E-953E-4992-A201-11E86216DFB4 Q37684132-AA88F70F-3944-4C40-92E7-E0F246ECCBF5 Q37802043-F8B01BA2-06DF-4176-85E1-5E5E6EE5D842 Q38027408-15D3111A-80D2-44DD-8C10-52EA60EB07D8 Q38170004-BFBC148E-E628-48B0-8423-7B8C2FBC98EE Q38241688-894B4033-CCA9-4AB6-8915-8A8E9349BAD5 Q38465648-8D5B8635-4ED3-492B-8BFD-3B0D4D411511 Q38711921-8180C3DD-5A3C-48E7-A60F-25ECBB1E5D09 Q38758695-D254350C-5F98-4BA8-B270-B731FFE6AADD Q38876699-7CCEA98E-8667-4496-BC3D-4FCE2AE31CAF Q38954615-70459A40-733B-4392-8509-502541BE05D9 Q39028183-71D296DD-CE64-4CD5-BDB9-15EED37AF05A Q42364240-4DA666E4-DBD8-4EED-A354-749510ED7DEE Q45073732-A144BE0D-F1BC-4AC8-BD18-CD13F444CB97 Q46076973-6F2C03CC-7415-4852-AC03-DC229409435F Q47634187-24C89B88-B35F-4A55-8597-8368A2FE2798

P2860

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q35183015

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

@ast

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

@en

type

label

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

@ast

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

@en

prefLabel

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

@ast

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

@en

P1433

Q35183015-48E20528-ACFA-4C1B-A34C-953354FA4DAE

P1476

Q35183015-333E5689-133F-4BFD-8328-E1C6AE38EB6F

P2093

Q35183015-2A120877-BB90-4A4C-BAFD-6EB8BF34CAA1

Q35183015-35750C24-7E99-4A77-A3CA-B507531A6934

Q35183015-5F5D23EC-CC55-421A-838F-F282764B7E17

Q35183015-6680EBBF-5372-4DDA-901C-0CACAF2F8277

Q35183015-6A5074FE-AB67-449B-A102-B657E6DAF9E9

Q35183015-778F4897-E241-47B8-833A-C61B03220B2E

Q35183015-9353EE0B-5F2D-464D-BE28-6BA949C8C6DA

Q35183015-94F6C46D-BD2A-4551-BCA2-AB34F5340E5C

Q35183015-9EAADBD4-CF05-4BD8-9C5E-CF007D8656AA

Q35183015-B1C65E48-B4CA-40B4-887B-DD0801663834

P2860

Q35183015-00B049A6-8058-43CE-B1FA-8516095FE427

Q35183015-09935FF9-DBEF-420B-8C90-4B03CF47E5E6

Q35183015-0AD27223-D918-409A-A570-DED330125C39

Q35183015-0D63E693-DD22-4516-B24F-9D89A76FC9A9

Q35183015-14EDC013-248E-4A5D-96E6-BC97C342F7EC

Q35183015-17931B5D-7F41-4812-9B1B-1CDEF7D2F189

Q35183015-1AD62FFA-8264-4282-8BFF-F50A8A6DAE77

Q35183015-1F822CF7-4933-4E3B-B28F-17D46E91A9EE

Q35183015-32F4ABF6-DF6E-4A53-A7FB-BFB58F7005F3

Q35183015-3DA58C18-D1FC-43C6-9F5B-663076023180

P2888

Q35183015-CD8DF253-1AB0-4A32-91F1-8E41C742A5B2

P304

Q35183015-CB623BA1-C193-483F-B976-3E48189AAE28

P31

Q35183015-D0FBE061-F569-473A-B93D-FA56D847E413

P356

Q35183015-319703F4-1B6E-4FD8-A528-FF8D426B9DCC

P433

Q35183015-86692778-815F-4943-A0F7-4515A4359D02

P478

Q35183015-68D86938-047A-4C4A-A94B-908FDAA1EC20

P577

Q35183015-7F300537-834C-4B8B-B829-61EFCA00A65D

P698

Q35183015-2261F1E0-D02A-499D-BFE2-19F63BB8F212

P921

Q35183015-0B1191F4-7B3A-4BE7-A297-05D794327FA7

Q35183015-FD6A68B6-797C-4F6F-B5A5-7EE3B470BB3E

P932

Q35183015-119F7395-DB98-46B8-8EED-093FEB9119AC

P356

P1433

P1476

Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

@en

P2093

A Bahlo

http://www.w3.org/2001/XMLSchema#string

B J Gross

http://www.w3.org/2001/XMLSchema#string

D E Spaner

http://www.w3.org/2001/XMLSchema#string

F Wen

http://www.w3.org/2001/XMLSchema#string

G W Hart

http://www.w3.org/2001/XMLSchema#string

J P Deans

http://www.w3.org/2001/XMLSchema#string

J Tomic

http://www.w3.org/2001/XMLSchema#string

J W Dennis

http://www.w3.org/2001/XMLSchema#string

J Zuccolo

http://www.w3.org/2001/XMLSchema#string

R Harrison

http://www.w3.org/2001/XMLSchema#string

P2860

cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse

Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression

Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase

Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins

Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition

Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats

Tumor cell metabolism: cancer's Achilles' heel

Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.

Albumin-associated lipids regulate human embryonic stem cell self-renewal.

Efficient isolation of highly purified tonsil B lymphocytes using RosetteSep with allogeneic human red blood cells

P2888

P304

1588-1598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2010.152

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20668475

http://www.w3.org/2001/XMLSchema#string

P921

P932

4361888

http://www.w3.org/2001/XMLSchema#string